0
How does Myriad conduct BART testing?
- 1 people answered
0 Vote
1 Contributor
1356 Views 
0 Saved
0 Vote 1 Contributor1356 Views 0 SavedYou might also be interested in
Don’t worry, most breast cysts can be very small and will only show up on ultrasound scans, and these are termed microcysts. About 25% of breast cysts enlarge gradually into ‘big-enough’ cysts to become a palpable breast lump. Breast cysts are extremely common, and occur in as many as one third of ....
Homeopathy is one of the most common complementary therapies used by people with cancer. Although there have been many research studies into homeopathy there is no scientific or medical evidence that it can prevent cancer or work as a cancer treatment. Homeopathy is based on the theory of trea....
When you think about breast cancer, what do you think of? A young woman with nipple discharge? Probably not. And that's because we often associate a lump as a sign of breast cancer, as well as assuming it only affects older women. But what about the other symptoms? There are some lesser known ind....
Mahima Chaudhary
Imagine going in for a cancer screening, and the technician turns to you and says, "We're finished, but if I push this button over here, the machine can detect even smaller cancers. But here's the hitch: You have to pay $700 if you want me to push this button."
Myriad Genetics is doing something very similar with BART tests that determine if a woman has a potentially dangerous genetic abnormality linked to breast cancers.
When testing shows that a woman carries a bad gene, she has a much higher chance of getting breast cancer. These women usually then get more frequent MRIs, ultrasounds and mammograms to detect cancer.
Myriad owns the patent on breast cancer genes and so is the only company that can test for them. It offers one test that catches most, but not all, abnormalities, and then charges nearly all patients $700 for a second test that catches the rest.
If a woman can't afford the $700 fee, she may miss an abnormality, which could mean the difference between life and death.
Myriad defends the $700 charge for its second test, called BART, even though many patients can't afford it and insurance won't pay for it.